Oxygen Biotherapeutics, Inc. (NASDAQ: OXBT), a development stage biomedical company focused on developing oxygen-carrying intravenous and topical products, announced today that it has entered into a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback